Neumann Advisory Hong Kong Ltd has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity securities portfolio as of the close of business on September 30, 2026. The filing was submitted on October 8, 2026, and lists Catherine Leung, the Managing Director of the firm, as the authorized signatory.
The report details the firm's holdings in 5 separate equity securities. The largest position disclosed in the filing is in Tesla Inc., where Neumann Advisory holds 649,768 shares. The firm also holds a significant position in Sinovac Biotech Ltd, with 315,586 shares. Other disclosed positions include Agora Inc. with 193,375 shares, Alphabet Inc. Class A with 170,739 shares, and Meta Platforms Class A with 30,537 shares. All positions are listed as sole voting and dispositive power.
